Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Más filtros

Bases de datos
Tipo del documento
Intervalo de año de publicación
1.
Biomed Pharmacother ; 173: 116397, 2024 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-38479181

RESUMEN

Angiosarcoma is a rare soft tissue sarcoma originating from endothelial cells. Given that current treatments for advanced disease have shown limited efficacy, alternative therapies need to be identified. In rare diseases, patient-derived cell models are crucial for screening anti-tumour activity. In this study, cell line models were characterised in 2D and 3D cultures. The cell lines' growth, migration and invasion capabilities were explored, confirming them as useful tools for preclinical angiosarcoma studies. By screening a drug library, we identified potentially effective compounds: 8-amino adenosine impacted cell growth and inhibited migration and invasion at considerably low concentrations as a single agent. No synergistic effect was detected when combining with paclitaxel, gemcitabine or doxorubicin. These results suggest that this compound could be a potentially useful drug in the treatment of AGS.


Asunto(s)
Hemangiosarcoma , Sarcoma , Humanos , Hemangiosarcoma/tratamiento farmacológico , Células Endoteliales/patología , Doxorrubicina/farmacología , Doxorrubicina/uso terapéutico , Sarcoma/tratamiento farmacológico , Paclitaxel/farmacología , Paclitaxel/uso terapéutico
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA